Skip to main content
Christopher King, MD, Cardiology, Birmingham, AL

ChristopherAKingMD

Cardiology Birmingham, AL

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Dr. King is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. King's full profile

Already have an account?

  • Office

    3686 Grandview Pkwy
    Ste 720
    Birmingham, AL 35243
    Phone+1 205-971-7500

Education & Training

  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemFellowship, Cardiovascular Disease, 2006 - 2009
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 2003 - 2006
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 2003

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2004 - 2024
  • TX State Medical License
    TX State Medical License 2012 - 2012
  • VA State Medical License
    VA State Medical License 2006 - 2012
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2012-2013
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • ‘Always Keep Moving’: Dr. Christopher King Specializes in Treating Tough Cardiovascular Disease
    ‘Always Keep Moving’: Dr. Christopher King Specializes in Treating Tough Cardiovascular DiseaseFebruary 4th, 2020
  • Warfarin Found to Increase Adverse Outcomes Among Transplant Patients IPF
    Warfarin Found to Increase Adverse Outcomes Among Transplant Patients IPFMay 31st, 2019

Professional Memberships